SRx Health Solutions, Inc. (SRXH): Nasdaq/NYSE listing notice — Better Choice receives NYSE American non-compliance notice for low stock price; cure period to March 21, 2024

SRx Health Solutions, Inc.

NYSE American notified Better Choice on Sept 21, 2023 that common stock traded at low price per share for substantial period, violating Section 1003(f)(v).
Cure period ends March 21, 2024; compliance may require reverse stock split or sustained price improvement; stock will trade with 'BC' designation.
Company intends to regain compliance and is in discussions with NYSE American; no immediate delisting or impact on business/SEC reporting.
Company supplemented risk factors in Form 10-K regarding potential delisting consequences such as reduced liquidity and penny stock designation.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SRx Health Solutions, Inc. received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 1003(f)(v)

Exact text from the filing

September 21, 2023, Better Choice Company, Inc. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (“Section 1003(f)(v)”) because shares of the Company's common stock have been selling for a substantial period of time at a low price per share. The Notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-033097

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.